Article Details

Neurimmune inks US-$760 deal with AstraZeneca - European Biotechnology

Retrieved on: 2022-01-09 18:38:00

Tags for this article:

Click the tags to see associated articles and topics

Neurimmune inks US-$760 deal with AstraZeneca - European Biotechnology. View article details on hiswai:

Excerpt

Neurimmune has entered into a collaboration and license agreement with AstraZeneca subsidiary Alexion Pharmaceuticals to commercialise its ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up